Literature DB >> 15824858

Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration.

Yen-Chen Huang1, Darnell Kaigler, Kevin G Rice, Paul H Krebsbach, David J Mooney.   

Abstract

UNLABELLED: Bone formation is a coordinated process involving various biological factors. We have developed a scaffold system capable of sustained and localized presentation of osteogenic (BMP-4) and angiogenic (VEGF) growth factors and human bone marrow stromal cells to promote bone formation at an ectopic site. Combined delivery of these factors significantly enhanced bone formation compared with other conditions.
INTRODUCTION: Tissue regeneration entails complex interactions between multiple signals and materials platforms. Orchestrating the presentation of these signals may greatly enhance the regeneration of lost tissue mass. Bone formation, for example, is dependent on the signaling of BMPs, molecules initiating vascularization (e.g., vascular endothelial growth factor [VEGF]), and osteogenic precursor cells capable of responding to these cues and forming bone tissue. It was hypothesized that combined and concerted delivery of these factors from biodegradable scaffolds would lead to enhanced bone formation.
MATERIALS AND METHODS: Poly(lactic-co-glycolic acid) scaffolds containing combinations of condensed plasmid DNA encoding for BMP-4, VEGF, and human bone marrow stromal cells (hBMSCs) were implanted into the subcutaneous tissue of SCID mice. Implants (n = 6) were retrieved at 3, 8, and 15 weeks after implantation. Bone and blood vessel formation was determined qualitatively and quantitatively by methods including histology, immmunostaining, and muCT.
RESULTS: Scaffolds delivering VEGF resulted in a prominent increase in blood vessel formation relative to the conditions without VEGF. BMP-4 expression in scaffolds encapsulating condensed DNA was also confirmed at the 15-week time-point, showing the characteristic of long-term delivery in this system. Combined delivery of all three types of factors resulted in a significant increase in the quantity of regenerated bone compared with any factor alone or any two factors combined, as measured with DXA, X-ray, and histomorphometric analysis. Furthermore, bone formed with all three factors had elastic moduli significantly higher than any other condition.
CONCLUSIONS: Concerted delivery of BMP-4, VEGF, and hBMSCs promoted greater bone formation relative to any single factor or combination of two factors. Materials systems that allows multifactorial presentation more closely mimic natural developmental processes, and these results may have important implications for bone regeneration therapeutics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15824858     DOI: 10.1359/JBMR.041226

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  100 in total

1.  Bioceramic-mediated trophic factor secretion by mesenchymal stem cells enhances in vitro endothelial cell persistence and in vivo angiogenesis.

Authors:  Jiawei He; Martin L Decaris; J Kent Leach
Journal:  Tissue Eng Part A       Date:  2012-06-07       Impact factor: 3.845

Review 2.  Strategies for controlled delivery of growth factors and cells for bone regeneration.

Authors:  Tiffany N Vo; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2012-02-04       Impact factor: 15.470

3.  Runx2 overexpression in bone marrow stromal cells accelerates bone formation in critical-sized femoral defects.

Authors:  Abigail M Wojtowicz; Kellie L Templeman; Dietmar W Hutmacher; Robert E Guldberg; Andrés J García
Journal:  Tissue Eng Part A       Date:  2010-09       Impact factor: 3.845

4.  Evaluation of dense polylactic acid/beta-tricalcium phosphate scaffolds for bone tissue engineering.

Authors:  Laura Yanoso-Scholl; Justin A Jacobson; Gino Bradica; Amy L Lerner; Regis J O'Keefe; Edward M Schwarz; Michael J Zuscik; Hani A Awad
Journal:  J Biomed Mater Res A       Date:  2010-12-01       Impact factor: 4.396

5.  Mimicking the nanostructure of bone matrix to regenerate bone.

Authors:  Robert Kane; Peter X Ma1
Journal:  Mater Today (Kidlington)       Date:  2013-11-01       Impact factor: 31.041

Review 6.  Inductive tissue engineering with protein and DNA-releasing scaffolds.

Authors:  David M Salvay; Lonnie D Shea
Journal:  Mol Biosyst       Date:  2005-11-25

7.  Nanoscale cell adhesion ligand presentation regulates nonviral gene delivery and expression.

Authors:  Hyun Joon Kong; Susan Hsiong; David J Mooney
Journal:  Nano Lett       Date:  2007-01       Impact factor: 11.189

Review 8.  Growth factor delivery for oral and periodontal tissue engineering.

Authors:  Darnell Kaigler; Joni A Cirelli; William V Giannobile
Journal:  Expert Opin Drug Deliv       Date:  2006-09       Impact factor: 6.648

Review 9.  Tissue engineered bone grafts: biological requirements, tissue culture and clinical relevance.

Authors:  Mirjam Fröhlich; Warren L Grayson; Leo Q Wan; Darja Marolt; Matej Drobnic; Gordana Vunjak-Novakovic
Journal:  Curr Stem Cell Res Ther       Date:  2008-12       Impact factor: 3.828

10.  Molecular imaging of expression of vascular endothelial growth factor a (VEGF a) in femoral bone grafts transplanted into living mice.

Authors:  Olga Strachna; Daniel Torrecilla; Marie K Reumann; Inna Serganova; Jihye Kim; Simone Gieschler; Adele L Boskey; Ronald G Blasberg; Philipp Mayer-Kuckuk
Journal:  Cell Transplant       Date:  2013-04-12       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.